NovoCure (NVCR) Return on Capital Employed (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,380.00 |
| Dec 31, 2025 | 1,560.00 |
| Sep 30, 2025 | 122.00 |
| Jun 30, 2025 | -145.00 |
| Mar 31, 2025 | 263.00 |
| Dec 31, 2024 | -293.00 |
| Sep 30, 2024 | -1,441.00 |
| Jun 30, 2024 | 345.00 |
| Mar 31, 2024 | 208.00 |
| Dec 31, 2023 | -156.00 |
| Sep 30, 2023 | -378.00 |
| Jun 30, 2023 | -434.00 |
| Mar 31, 2023 | -566.00 |
| Dec 31, 2022 | -193.00 |
| Sep 30, 2022 | -153.00 |
| Jun 30, 2022 | -85.00 |
| Mar 31, 2022 | 6.00 |
| Dec 31, 2021 | -359.00 |
| Sep 30, 2021 | -242.00 |
| Jun 30, 2021 | -202.00 |
| Mar 31, 2021 | -129.00 |
| Dec 31, 2020 | 4.00 |
| Sep 30, 2020 | 311.00 |
| Jun 30, 2020 | 125.00 |
| Mar 31, 2020 | 69.00 |
| Dec 31, 2019 | 258.00 |
| Sep 30, 2019 | 316.00 |
| Jun 30, 2019 | 356.00 |
| Mar 31, 2019 | 325.00 |
| Dec 31, 2018 | -164.00 |
| Sep 30, 2018 | 39.00 |
| Jun 30, 2018 | 457.00 |
| Mar 31, 2018 | 229.00 |
| Dec 31, 2017 | 569.00 |
| Sep 30, 2017 | 916.00 |
| Jun 30, 2017 | 682.00 |
| Mar 31, 2017 | 611.00 |
| Dec 31, 2016 | 693.00 |
| Sep 30, 2016 | 78.00 |
| Jun 30, 2016 | -1,067.00 |
| Mar 31, 2016 | 585.00 |